Evidence of Ruptured Membranes in Women Greater Than 15 Weekd Clinical Trial
Official title:
A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes
NCT number | NCT02208011 |
Other study ID # | L8608-W13010 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 2014 |
Est. completion date | June 2015 |
Verified date | August 2020 |
Source | Louisiana State University, Baton Rouge |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Specific objectives include analysis of performance of ROM Plus® in diagnosing ROM, as
compared to Amnisure® and the conventional clinical assessment confirmed by a thorough chart
review after delivery.
Inclusion Criteria:
- English speaking
- pregnant woman >15 weeks gestation undergoing an exam for ruptured membranes
Exclusion Criteria:
- Known placental previa
- Active vaginal bleeding
Status | Completed |
Enrollment | 140 |
Est. completion date | June 2015 |
Est. primary completion date | June 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - complaint of ruptured membranes - IUP > 15 weeks gestation - English speaking, over the age of 18yrs old Exclusion Criteria: - active bleeding - placenta previa |
Country | Name | City | State |
---|---|---|---|
United States | Woman's Hospital | Baton Rouge | Louisiana |
Lead Sponsor | Collaborator |
---|---|
Louisiana State University, Baton Rouge | Clinical Innovations, LLC, Louisiana State University Health Sciences Center in New Orleans, Woman's Hospital, Louisiana |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | evidence of ruptured membranes | up to delivery of infant |